Verrica Pharmaceuticals Q3 EPS $(0.24) Up From $(0.27) YoY

Verrica Pharmaceuticals (NASDAQ:VRCA) reported quarterly losses of $(0.24) per share. This is a 11.11 percent increase over losses of $(0.27) per share from the same period last year.

Benzinga · 11/06/2019 21:15

Verrica Pharmaceuticals (NASDAQ:VRCA) reported quarterly losses of $(0.24) per share. This is a 11.11 percent increase over losses of $(0.27) per share from the same period last year.